- Home
- VYNE vs XCUR Comparison
VYNE vs XCUR Comparison
Compare VYNE & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- XCUR
- Stock Information
- Founded
- VYNE 2003
- XCUR 2011
- Country
- VYNE United States
- XCUR United States
- Employees
- VYNE N/A
- XCUR N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- VYNE Health Care
- XCUR Health Care
- Exchange
- VYNE Nasdaq
- XCUR Nasdaq
- Market Cap
- VYNE 41.9M
- XCUR 39.9M
- IPO Year
- VYNE 2018
- XCUR N/A
- Fundamental
- Price
- VYNE $2.49
- XCUR $18.40
- Analyst Decision
- VYNE Strong Buy
- XCUR
- Analyst Count
- VYNE 2
- XCUR 0
- Target Price
- VYNE $6.88
- XCUR N/A
- AVG Volume (30 Days)
- VYNE 70.8K
- XCUR 578.3K
- Earning Date
- VYNE 11-07-2024
- XCUR 11-14-2024
- Dividend Yield
- VYNE N/A
- XCUR N/A
- EPS Growth
- VYNE N/A
- XCUR N/A
- EPS
- VYNE N/A
- XCUR N/A
- Revenue
- VYNE $493,000.00
- XCUR $500,000.00
- Revenue This Year
- VYNE $28.30
- XCUR N/A
- Revenue Next Year
- VYNE N/A
- XCUR N/A
- P/E Ratio
- VYNE N/A
- XCUR N/A
- Revenue Growth
- VYNE 39.27
- XCUR N/A
- 52 Week Low
- VYNE $1.57
- XCUR $1.44
- 52 Week High
- VYNE $3.43
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- VYNE 40.82
- XCUR 51.82
- Support Level
- VYNE $2.34
- XCUR $15.37
- Resistance Level
- VYNE $2.69
- XCUR $19.22
- Average True Range (ATR)
- VYNE 0.19
- XCUR 3.49
- MACD
- VYNE -0.04
- XCUR -1.13
- Stochastic Oscillator
- VYNE 13.79
- XCUR 30.37
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.